JNJ-47910382
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for JNJ-47910382, covering 2013-02-20 to 2014-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382 [Phase 1]